Apyx Medical (APYX) Accumulated Depreciation & Amortization (2016 - 2025)
Apyx Medical (APYX) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $4.1 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 23.17% year-over-year to $4.1 million, compared with a TTM value of $4.1 million through Dec 2025, up 23.17%, and an annual FY2025 reading of $4.1 million, up 23.17% over the prior year.
- Accumulated Depreciation & Amortization was $4.1 million for Q4 2025 at Apyx Medical, up from $3.4 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $4.1 million in Q4 2025 and bottomed at $157000.0 in Q1 2024.
- Average Accumulated Depreciation & Amortization over 5 years is $891437.5, with a median of $506000.0 recorded in 2022.
- The sharpest move saw Accumulated Depreciation & Amortization decreased 25.0% in 2023, then skyrocketed 384.68% in 2024.
- Year by year, Accumulated Depreciation & Amortization stood at $903000.0 in 2021, then dropped by 1.44% to $890000.0 in 2022, then decreased by 22.25% to $692000.0 in 2023, then surged by 384.68% to $3.4 million in 2024, then increased by 23.17% to $4.1 million in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for APYX at $4.1 million in Q4 2025, $3.4 million in Q4 2024, and $313000.0 in Q2 2024.